ストックスクリーナーアプリを入手
1.81
9.04%
0.15
前日終値:
$1.66
開ける：
$1.7
24時間の取引高:
5,688
Relative Volume:
0.13
時価総額：
$15.95M
収益：
-
当期純損益:
$-2.25M
株価収益率:
-4.525
EPS:
-0.4
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.69%
1か月 パフォーマンス:
+25.69%
6か月 パフォーマンス:
-29.57%
1年 パフォーマンス:
+115.48%
1日の値動き範囲:
$1.70
$1.82
1週間の範囲:
$1.6553
$1.85
52週間の値動き範囲:
$0.7681
$4.9897
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
XTLB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
1.81 | 15.95M | 0 | -2.25M | 0 | -0.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-05-08 | 開始されました | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr (XTLB) 最新ニュース
XTL Biopharmaceuticals Expands Portfolio with Social Proxy Acquisition Amidst Regional Challenges - TipRanks
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion - TipRanks
XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks
XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher - Markets Insider
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - Yahoo Finance
X T L Biopharmaceuticals Ltd Adr (XTLB) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):